N

NEVRO Corp
D

NVRO

5.73500
USD
0.01
(0.09%)
مغلق
حجم التداول
20,607
الربح لكل سهم
-3
العائد الربحي
-
P/E
-3
حجم السوق
217,103,810
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    A
    ALGN
    -7.520
    (-3.80%)
    190.370 USD
    B
    BAX
    0.425
    (1.27%)
    33.840 USD
    BSX
    BSX
    -0.840
    (-0.80%)
    104.480 USD
    EW
    EW
    -1.380
    (-1.85%)
    73.300 USD
    ISRG
    ISRG
    -15.37
    (-2.53%)
    591.50 USD
    MDT
    MDT
    2.000
    (2.27%)
    89.940 USD
    SYK
    SYK
    -3.72
    (-0.96%)
    382.74 USD
    TMO
    TMO
    -5.71
    (-1.06%)
    532.28 USD
    ZBH
    ZBH
    1.250
    (1.21%)
    104.890 USD
    المزيد
الأخبار
المقالات

العنوان: NEVRO Corp

القطاع: Healthcare
الصناعة: Medical Devices
Nevro Corp is a medical device company. Its key product is the HFX spinal cord stimulation (SCS) platform, which includes the Senza SCS system, an evidence-based neuromodulation system for the treatment of chronic pain. Senza generates electrical impulses to relieve pain. The system is implanted by physicians and controlled by patients. It consists of leads, a trial stimulator, an implantable pulse generator, surgical tools, a clinician laptop programmer, a patient remote control, and a mobile charger. The company generates the majority of its revenue in the United States.